Click a link below to view the mailing archive as if it had been sent to you.
| 2025-06-30 12:15 | | AbbVie reels in Capstan in $2.1B buyout, charting course for in vivo CAR-T market and more... |
| 2025-06-30 00:15 | | New Total Ankle Replacement System from Stryker Gets FDA Clearance and more... |
| 2025-06-27 12:15 | | ACIP skips votes on COVID and Moderna’s mRESVIA but scrutinzes mRNA vaccine safety and more... |
| 2025-06-27 00:15 | | Kennedy’s US vaccine panel backs preservative-free shot despite safety evidence and more... |
| 2025-06-26 12:15 | | Altimmune's stock sinks on mixed phase 2 MASH results for GLP-1 drug and more... |
| 2025-06-26 00:15 | | TIGIT Turmoil: How Pharma Burned Billions on Failed Immuno-Oncology Projects and more... |
| 2025-06-25 12:15 | | Prescription drug sales will hit $1.75T by 2030 thanks to GLP-1s: Evaluate and more... |
| 2025-06-25 00:15 | | Lexeo to help launch spinout around RNA drugs for the heart and more... |
| 2025-06-24 12:15 | | Novo Nordisk launches blockbuster weight-loss drug Wegovy in India and more... |
| 2025-06-24 00:15 | | Eli Lilly seeks green light for weekly insulin after strong trial results and more... |
| 2025-06-23 12:15 | | Illumina bets on proteomics with $425m SomaLogic purchase and more... |
| 2025-06-23 00:15 | | A waste business buy, slashing salaries for all staff: 4 strange strategies biotechs are using to stay alive and more... |
| 2025-06-20 12:15 | | Gene therapy faces fresh uncertainty as two more top FDA officials depart and more... |
| 2025-06-19 00:15 | | FDA approves twice-yearly shot of Gilead drug for HIV prevention and more... |
| 2025-06-18 12:15 | | US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list and more... |
| 2025-06-18 00:15 | | FDA launches new priority review voucher program for biopharmas that ‘align with national priorities’ and more... |
| 2025-06-17 12:15 | | Lilly to acquire Verve in $1B bet on gene editing for heart disease and more... |
| 2025-06-17 00:15 | | Makary says he wants nimbler FDA, calls for new drug pathways and pilots and more... |
| 2025-06-16 12:15 | | All US state attorneys general agree to $7.4 billion Purdue Pharma settlement and more... |
| 2025-06-13 12:15 | | Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation and more... |
| 2025-06-13 00:15 | | Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease and more... |
| 2025-06-12 12:15 | | BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal and more... |
| 2025-06-12 00:15 | | RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel and more... |
| 2025-06-11 12:15 | | BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal and more... |
| 2025-06-11 00:15 | | Scorpion, fresh off Lilly deal, spins out startup Antares and more... |
| 2025-06-10 12:15 | | Novo Nordisk starts new CagriSema weightloss drug trial and more... |
| 2025-06-10 00:15 | | RFK Jr. boots all members of the CDC's vaccine advisory committee and more... |
| 2025-06-09 12:15 | | Merck claims study success with PCSK9 cholesterol pill and more... |
| 2025-06-07 00:15 | | Novartis presses court for hasty decision in long-running Entresto patent feud with MSN and more... |
| 2025-06-06 12:15 | | Valneva reports data from Phase II chikungunya vaccine trial in children and more... |
| 2025-06-06 00:15 | | uniQure’s regulatory progress sparks optimism for ‘desperate’ Huntington’s space and more... |
| 2025-06-05 12:15 | | GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds and more... |
| 2025-06-05 00:15 | | Merck gains U.S. patent office support in Keytruda dispute and more... |
| 2025-06-04 12:15 | | Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says and more... |
| 2025-06-04 00:15 | | ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons and more... |
| 2025-06-03 12:15 | | Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech: FT and more... |
| 2025-06-03 00:15 | | Trump administration proposes cutting FDA budget by 5.5% and more... |
| 2025-06-02 12:15 | | Gilead's CAR-T cell therapy shows promise in deadly brain cancer and more... |
